kisspeptin third party tested

Evaluating kisspeptin third party tested documentation requires rigorous verification of analytical data, including high-performance liquid chromatography and mass spectrometry. PX1 Research provides lot-specific Certificates of Analysis for every batch of research peptides to ensure institutional-grade reproducibility. Our USA-manufactured compounds undergo independent ISO 17025 testing to guarantee maximum purity for preclinical protocols.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Evaluating kisspeptin third party tested documentation requires rigorous verification of analytical data, including high-performance liquid chromatography and mass spectrometry. PX1 Research provides lot-specific Certificates of Analysis for every batch of research peptides to ensure institutional-grade reproducibility. Our USA-manufactured compounds undergo independent ISO 17025 testing to guarantee maximum purity for preclinical protocols.

Reviewed by PX1 Research scientific team

Key takeaways

  • Acquiring [kisspeptin](/research-peptides/kisspeptin-10) third party tested materials ensures that in vitro and animal models yield consistent, reproducible data without interference from synthesis impurities or residual solvents.
  • Standard chemical synthesis of decapeptides like [Kisspeptin](/research-peptides/kisspeptin-10)-10 (Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2) can introduce truncated sequences, deletion peptides, or residual protecting groups.
  • Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant confounder in cellular assays and animal studies.
  • The integrity of preclinical signaling data depends directly on the manufacturing standards of the baseline compounds.

Kisspeptin Third Party Tested: Verification Standards for Laboratory Research

Acquiring kisspeptin third party tested materials ensures that in vitro and animal models yield consistent, reproducible data without interference from synthesis impurities or residual solvents. A verified Kisspeptin-10 sequence must be backed by an independent Certificate of Analysis (COA) specifying chemical identity, net peptide content, and absolute purity.

At PX1 Research, every batch of Kisspeptin-10 is subjected to a dual-assay testing protocol conducted by accredited third-party laboratories. This workflow utilizes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chromatographic purity assessment and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm sequence integrity. Investigators can cross-reference batch documentation via our comprehensive spec lot testing guide to verify sequence fidelity prior to protocol initiation.

Analytical Criteria for Kisspeptin-10 Quality Verification

Standard chemical synthesis of decapeptides like Kisspeptin-10 (Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2) can introduce truncated sequences, deletion peptides, or residual protecting groups. To safeguard qualitative experimental outcomes, analytical testing must differentiate the primary peptide peak from structurally related impurities.

RP-HPLC analysis establishes optical purity by measuring UV absorbance (typically at 214 nm and 280 nm) as the sample elutes through a C18 stationary phase. PX1 Research mandates a minimum purity threshold of ≥98.0% for all research peptides. Concurrently, ESI-MS verifies the exact molecular weight (1302.45 g/mol for Kisspeptin-10), ensuring that missing amino acid residues or post-translational modifications are absent. Detailed breakdowns of spectral analysis are accessible through our peptide purity standards guide.

Endotoxin Testing Protocols in Preclinical Research

Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant confounder in cellular assays and animal studies. In neuroendocrine research, exogenous endotoxins can trigger unintended inflammatory cascades, altering baseline gonadotropin secretion and confounding experimental results.

To prevent endotoxin-mediated artifacts, PX1 Research subjects all lot batches to Chromogenic Limulus Amebocyte Lysate (LAL) testing. Having kisspeptin third party tested for endotoxin content guarantees levels strictly below 0.1 EU/mg. This level of verification is critical for sensitive in vitro receptor binding assays and microinfusion studies in rodent models. Researchers interested in bulk acquisition for high-throughput screening can review our wholesale lab account options for customized lot reservations.

USA Manufacturing and ISO 17025 Laboratory Verification

The integrity of preclinical signaling data depends directly on the manufacturing standards of the baseline compounds. PX1 Research synthesizes all peptide sequences in domestic, GMP-compliant facilities located in the United States. Domestic synthesis eliminates international supply chain vulnerabilities and minimizes exposure to temperature fluctuations during transit.

Following synthesis and lyophilization, independent samples are dispatched to ISO 17025 accredited testing facilities. These third-party analytical laboratories operate independently of the manufacturing facility, preventing conflict of interest and ensuring unbiased reporting. Full analytical documentation, including raw chromatograms and mass spectra, is permanently archived in the PX1 Research Hub for public review and institutional compliance audit trails.

Mechanism of Action: Kisspeptin-10 in HPG Axis Upstream Signaling

Kisspeptin-10 serves as a primary endogenous ligand for the G-protein coupled receptor KIR2.1 (also designated KISS1R or GPR54). In preclinical neuroendocrine models, activation of KISS1R on GnRH neurons in the hypothalamus stimulates the pulsatile release of Gonadotropin-Releasing Hormone (GnRH). This upstream cascade regulates downstream pituitary secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).

Because Kisspeptin-10 acts as a master regulator of the hypothalamic-pituitary-gonadal (HPG) axis, experimental models utilize the peptide to investigate central reproductive signaling, pubertal timing, and feedback mechanisms mediated by sex steroids. In vitro data indicate that Kisspeptin-10 binding triggers intracellular calcium mobilization and extracellular signal-regulated kinase (ERK) phosphorylation, establishing its utility in second-messenger signal transduction studies.

Comparative Analysis: Kisspeptin-10 vs. Related HPG Axis Research Peptides

Evaluating neuroendocrine pathways often requires comparative studies using multiple ligands targeting different nodes of the HPG axis. While Kisspeptin-10 functions upstream at the hypothalamic level, other small molecules and peptides act directly at the anterior pituitary or gonadal level.

For example, researchers studying central stimulation typically compare Kisspeptin-10 against direct GnRH receptor agonists such as gonadorelin, triptorelin, and leuprolide. While gonadorelin directly activates pituitary GnRH receptors to induce LH/FSH release, Kisspeptin-10 operates one step higher in the regulatory hierarchy by modulating GnRH neuronal firing. A comparative analysis of these mechanisms is outlined below:

Comparative HPG Axis Compound Specifications

• Kisspeptin-10: Upstream Hypothalamic Target (KISS1R/GPR54); Primary Effect: Endogenous GnRH pulse generation; Molecular Weight: 1302.45 g/mol; Minimum Purity: ≥98.0%.

• Gonadorelin: Pituitary Target (GnRHR); Primary Effect: Direct LH/FSH secretion; Molecular Weight: 1182.3 g/mol; Minimum Purity: ≥98.0% (See gonadorelin).

• Triptorelin: Pituitary Target (GnRHR Agonist); Primary Effect: Sustained receptor activation/desensitization; Molecular Weight: 1311.45 g/mol; Minimum Purity: ≥98.0% (See triptorelin).

• Leuprolide: Pituitary Target (GnRHR Agonist); Primary Effect: Receptor downregulation in endocrine models; Molecular Weight: 1209.4 g/mol; Minimum Purity: ≥98.0% (See leuprolide).

Detailed signaling dynamics for these compounds can be explored in our comprehensive review on GnRH receptor agonists.

Reconstitution and Handling Protocols for Laboratory Research

Maintaining peptide stability during reconstituted handling is essential for preserving bioactivity in cellular and animal models. Kisspeptin-10 is supplied as a sterile, lyophilized cake designed for reconstitution in standard laboratory reagents.

For typical in vitro receptor assays, reconstitution in sterile Bacteriostatic Water or phosphate-buffered saline (PBS, pH 7.4) is recommended. The lyophilized powder should be allowed to equilibrate to room temperature before reconstitution to prevent moisture condensation. Gentle swirling without vortexing is recommended to prevent mechanical agitation and peptide aggregation. Detailed step-by-step procedures can be found in our dedicated guide on peptide storage protocols.

Temperature Stability and Storage Parameters

Lyophilized Kisspeptin-10 exhibits excellent long-term chemical stability when stored under controlled thermal conditions. For storage periods exceeding 30 days, the dry powder should be maintained at -20°C or -80°C in a desiccated environment to prevent hydrolysis.

Once reconstituted, aqueous solutions of Kisspeptin-10 should be aliquoted into single-use polypropylene tubes to avoid repeated freeze-thaw cycles, which degrade peptide bonds. Aliquots stored at 4°C should be utilized within 7 to 14 days, whereas frozen aliquots (-20°C) remain stable for up to 3 to 6 months depending on concentration and buffer composition.

Lot Traceability, Chain of Custody, and Fulfillment

PX1 Research enforces strict chain-of-custody protocols from synthesis through final dispatch. Every vial of Kisspeptin-10 is assigned a unique lot number linked directly to its corresponding HPLC chromatogram, mass spectrometry scan, and LAL endotoxin report.

To ensure minimal exposure to ambient temperatures during transit, all domestic orders ship directly from our fulfillment centers in California and Arizona. Orders placed before 12:00 PM PST (Monday through Friday) are dispatched same-day. Researchers requiring continuous supply lines for longitudinal studies can manage recurring orders via our wholesale lab account platform.

Frequently Asked Questions

What does it mean when kisspeptin is third party tested?

When kisspeptin is third party tested, it means an independent, ISO 17025 accredited analytical laboratory has independently verified the compound's chemical identity, purity percentage, and safety profile (such as endotoxin levels) using RP-HPLC and ESI-MS, separate from the manufacturer.

How do I verify the COA for Kisspeptin-10 from PX1 Research?

Every vial of Kisspeptin-10 features a batch/lot number printed on the label. Researchers can enter this lot number on the PX1 Research website to download the matching Certificate of Analysis containing complete HPLC chromatograms and mass spec reports.

What analytical methods are used to test Kisspeptin-10 purity?

Purity is evaluated using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to measure optical purity (≥98.0%), while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the precise molecular mass (1302.45 g/mol).

What is the acceptable endotoxin threshold for research-grade Kisspeptin-10?

PX1 Research mandates an endotoxin limit of less than 0.1 EU/mg, verified via Chromogenic LAL assay, to prevent inflammatory interference in preclinical models.

Where is PX1 Research Kisspeptin-10 manufactured?

All PX1 Research peptides are manufactured in cGMP-compliant facilities located within the United States before undergoing independent third-party testing.

How should lyophilized Kisspeptin-10 be stored upon arrival?

Lyophilized Kisspeptin-10 should be stored at -20°C or -80°C in a desiccated container to preserve stability for long-term research projects.

What diluents are recommended for reconstituting Kisspeptin-10 in vitro?

Sterile Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4) are commonly used for reconstituting Kisspeptin-10 for laboratory assay applications.

What receptor target does Kisspeptin-10 interact with in preclinical models?

Kisspeptin-10 acts as a high-affinity endogenous agonist for the G-protein coupled receptor KIR2.1 (KISS1R/GPR54), stimulating GnRH release in hypothalamic neuronal models.

How does Kisspeptin-10 differ mechanism of action from gonadorelin?

Kisspeptin-10 acts upstream at the hypothalamic level to stimulate GnRH neurons, whereas gonadorelin acts downstream directly on anterior pituitary GnRH receptors.

What are the shipping and fulfillment timelines for Kisspeptin-10 orders?

Orders placed Monday through Friday before 12:00 PM PST ship same-day from facilities located in California and Arizona to minimize thermal exposure during transit.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.